Genetic Analysis of Leishmania donovani Tropism Using a Naturally Attenuated Cutaneous Strain

PLoS Pathogens

Volumn 10, Issue 7, 2014, Pages

  Zhang, Wen Wei ^a   Ramasamy, Gowthaman ^b   McCall, Laura Isobel ^a   Haydock, Andrew ^b   Ranasinghe, Shalindra ^c   Abeygunasekara, Priyanka ^d   Sirimanna, Ganga ^e   Wickremasinghe, Renu ^c   Myler, Peter ^b   Matlashewski, Greg ^a  

^a MCGILL UNIVERSITY   (Canada)

^b SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF SRI JAYEWARDENEPURA   (Sri Lanka)

^d Teaching Hospital Anuradhapura   (Sri Lanka)

^e NATIONAL HOSPITAL OF SRI LANKA   (Sri Lanka)

Author keywords

[No Author keywords available]

Indexed keywords

PROTOZOAL PROTEIN;

ANIMAL; BAGG ALBINO MOUSE; FEMALE; GENE DELETION; GENETICS; HUMAN; IMMUNOLOGY; LEISHMANIA DONOVANI; MALE; MOUSE; PSEUDOGENE; SINGLE NUCLEOTIDE POLYMORPHISM; VISCERAL LEISHMANIASIS;

ANIMALS; FEMALE; GENE DELETION; HUMANS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MALE; MICE; MICE, INBRED BALB C; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTOZOAN PROTEINS; PSEUDOGENES;

EID: 84905365168     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004244     Document Type: Article

References (30)

1. Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, et al. (2012) Leishmaniasis Worldwide and Global Estimates of Its Incidence. Plos One 7: e35671.
2. Murray HW, Berman JD, Davies CR, Saravia NG, (2005) Advances in leishmaniasis. Lancet 366: 1561-1577.
3. McCall LI, Zhang WW, Matlashewski G, (2013) Determinants for the development of visceral leishmaniasis disease. PLoS Pathog 9: e1003053.
4. Karunaweera ND, Pratlong F, Siriwardane HVYD, Ihalamulla RL, Dedet JP, (2003) Lankan cutaneous leishmaniasis is caused by Leishmania donovani zymodeme MON-37. Transactions of the Royal Society of Tropical Medicine and Hygiene 97: 380-381.
5. Ranasinghe S, Wickremasinghe R, Munasinghe A, Hulangamuwa S, Sivanantharajah S, et al. (2013) Cross-Sectional Study to Assess Risk Factors for Leishmaniasis in an Endemic Region in Sri Lanka. Am J Trop Med Hyg 89: 742-749.
6. Siriwardana HVYD, Noyes HA, Beeching NJ, Chance ML, Karunaweera ND, et al. (2007) Leishmania donovani and cutaneous leishmaniasis, Sri Lanka. Emerging Infectious Diseases 13: 476-478.
7. Abeygunasekara PH, Costa YJ, Seneviratne N, Ratnatunga N, Wijesundera Mde S, (2007) Locally acquired visceral leishmaniasis in Sri Lanka. Ceylon Med J 52: 30-31.
8. Ranasinghe S, Zhang WW, Wickremasinghe R, Abeygunasekera P, Chandrasekharan V, et al. (2012) Leishmania donovani zymodeme MON-37 isolated from an autochthonous visceral leishmaniasis patient in Sri Lanka. Pathogens and global health 106: 421-424.
9. Zhang WW, Matlashewski G, (1997) Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2. Proc Natl Acad Sci U S A 94: 8807-8811.
10. Zhang WW, Matlashewski G, (2010) Screening Leishmania donovani-specific genes required for visceral infection. Mol Microbiol 77: 505-517.
11. Downing T, Imamura H, Decuypere S, Clark TG, Coombs GH, et al. (2011) Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance. Genome Research 21: 2143-2156.
12. Rogers MB, Hilley JD, Dickens NJ, Wilkes J, Bates PA, et al. (2011) Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania. Genome Research 21: 2129-2142.
13. Zhang WW, Matlashewski G, (2001) Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection. Mol Microbiol 39: 935-948.
14. Azzouni F, Mohler J, (2012) Role of 5alpha-reductase inhibitors in prostate cancer prevention and treatment. Urology 79: 1197-1205.
15. Qiu XB, Shao YM, Miao S, Wang L, (2006) The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperones. Cellular and molecular life sciences: CMLS 63: 2560-2570.
16. Dhir V, Goulding D, Field MC, (2004) TbRAB1 and TbRAB2 mediate trafficking through the early secretory pathway of Trypanosoma brucei. Molecular and Biochemical Parasitology 137: 253-265.
17. Sauve AA, Youn DY, (2012) Sirtuins: NAD(+)-dependent deacetylase mechanism and regulation. Current Opinion in Chemical Biology 16: 535-543.
18. Jewell JL, Guan KL, (2013) Nutrient signaling to mTOR and cell growth. Trends in Biochemical Sciences 38: 233-242.
19. Clayton CE, (2002) Life without transcriptional control? From fly to man and back again (vol 21, pg 1881, 2002). Embo Journal 21: 3917-3917.
20. da Silva LM, Beverley SM, (2010) Expansion of the target of rapamycin (TOR) kinase family and function in Leishmania shows that TOR3 is required for acidocalcisome biogenesis and animal infectivity. Proc Natl Acad Sci U S A 107: 11965-11970.
21. Sterkers Y, Lachaud L, Bourgeois N, Crobu L, Bastien, Pages M, (2012) Novel insights into genome plasticity in eukaryotes: mosaic aneuploidy in Leishmania. Mol Micro 86: 15-23.
22. Zhang WW, Mendez S, Ghosh A, Myler P, Ivens A, et al. (2003) Comparison of the A2 gene locus in Leishmania donovani and Leishmania major and its control over cutaneous infection. J Biol Chem 278: 35508-35515.
23. McCall LI, Matlashewski G, (2010) Localization and induction of the A2 virulence factor in Leishmania: evidence that A2 is a stress response protein. Mol Microbiol 77: 518-530.
24. McCall LI, Matlashewski G, (2012) Involvement of the Leishmania donovani virulence factor A2 in protection against heat and oxidative stress. Exp Parasitol 132: 109-115.
25. Ghedin E, Zhang WW, Charest H, Sundar S, Kenney RT, et al. (1997) Antibody response against a Leishmania donovani amastigote-stage-specific protein in patients with visceral leishmaniasis. Clin Diagn Lab Immunol 4: 530-535.
26. Diaz-Gonzalez R, Kuhlmann FM, Galan-Rodriguez C, Madeira da Silva L, Saldivia M, et al. (2011) The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposing. PLoS Negl Trop Dis 5: e1297.
27. Branquinha MH, Marinho FA, Sangenito LS, Oliveira SS, Goncalves KC, et al. (2013) Calpains: potential targets for alternative chemotherapeutic intervention against human pathogenic trypanosomatids. Current medicinal chemistry 20: 3174-3185.
28. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, et al. (2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43: 491.
29. Cingolani P, Platts A, Wang LL, Coon M, Nguyen T, et al. (2012) A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w(1118); iso-2; iso-3. Fly 6: 80-92.
30. Armour CD, Castle JC, Chen R, Babak T, Loerch P, et al. (2009) Digital transcriptome profiling using selective hexamer priming for cDNA synthesis. Nature methods 6: 647-649.